Cytogenetics and molecular genetics of acute lymphoblastic leukemia
- 27 June 2002
- journal article
- review article
- Published by Wiley in Reviews in Clinical and Experimental Hematology
- Vol. 6 (2) , 91-113
Abstract
An important factor in the diagnosis of acute lymphoblastic leukemia (ALL) is that karyotype is an independent prognostic indicator, with an impact on the choice of treatment. Outcome is related to the number of chromosomes. For example, high hyperdiploidy (51–65 chromosomes) is associated with a good prognosis, whereas patients with near haploidy (23–29 chromosomes) have a poor outcome. The discovery of recurring chromosomal abnormalities in the leukemic blasts of patients with ALL has identified a large number of genes involved in leukemogenesis. Certain specific genetic changes are related to prognosis. The ETV6/AML1 fusion arising from the translocation (t12;21) (p13;q22) has been associated with a good outcome; the BCR/ABL fusion of (t9;22)(q34;q11), rearrangements of the MLL gene, and abnormalities of the short arm of chromosomes 9 involving the tumor suppressor genes p16INK4A have a poor prognosis. Unfortunately, the classification of patients into prognostic groups based on cytogenetics is not always as predicted. Even when other clinically based risk factors are taken into account, some patients with good‐risk cytogenetic features will relapse. In the search for new measures of prognosis, it has recently emerged that the level of minimal residual disease following induction therapy can be a reliable predictor of outcome in ALL.Keywords
This publication has 123 references indexed in Scilit:
- Near haploid childhood acute lymphoblastic leukemia masked by hyperdiploid lineCancer Genetics and Cytogenetics, 2001
- Cytogenetic aberrations in adult acute lymphocytic leukemia: optimal technique may influence the resultsCancer Genetics and Cytogenetics, 2001
- t(7;12)(q36;p13) and t(7;12)(q32;p13) – translocations involving ETV6 in children 18 months of age or younger with myeloid disordersLeukemia, 2001
- Targeting the BCR-ABL Tyrosine Kinase in Chronic Myeloid LeukemiaNew England Journal of Medicine, 2001
- Monosomy 20 as a pointer to dicentric (9;20) in acute lymphoblastic leukemiaLeukemia, 2000
- Molecular genetics, natural history and the demise of childhood leukaemiaEuropean Journal of Cancer, 1999
- Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhoodThe Lancet, 1998
- Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XABritish Journal of Haematology, 1997
- The detection of E2A rearrangement or E2A‐PBXI fusion transcript in t(1;19) leukemia to the editorsGenes, Chromosomes and Cancer, 1995
- Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemiasCell, 1992